Yuki Gosei Kogyo : Non-Consolidated Financial Results for the Three Months Ended June 30, 2020
July 31, 2020 at 09:35 am IST
Share
Non-Consolidated Financial Results
for the Three Months Ended June 30, 2020
[Japanese GAAP]
July 31, 2020
Company name: YUKI GOSEI KOGYO CO., LTD.
Stock exchange listing: Tokyo Stock Exchange
Code number: 4531
URL: https://www.yuki-gosei.co.jp/
Representative: Seiichiro Matsumoto, President
Contact: Yasuhiko Yamato, Director and Senior Managing Executive Officer
Phone: +81-3-3664-3980
Scheduled date of filing quarterly securities report: August 13, 2020
Scheduled date of commencing dividend payments: -
Availability of supplementary briefing material on quarterly financial results: No
Schedule of quarterly financial results briefing session: No
(Amounts of less than one million yen are rounded down.)
1. Non-Consolidated Financial Results for the Three Months Ended June 30, 2020 (April 1, 2020 to June 30,
2020)
(1) Non-Consolidated Operating Results
(% indicates changes from the previous corresponding period.)
Net sales
Operating income
Ordinary income
Net income
Three months ended
Million yen
%
Million yen
%
Million yen
%
Million yen
%
June 30, 2020
2,591
0.2
(20)
-
(14)
-
(20)
-
June 30, 2019
2,585
15.6
24
-
49
-
25
-
Net income per share
Diluted net income
per share
Three months ended
Yen
Yen
June 30, 2020
(0.96)
-
June 30, 2019
1.15
-
(2) Non-Consolidated Financial Position
Total assets
Net assets
Equity ratio
Million yen
Million yen
%
As of June 30, 2020
20,671
10,491
50.8
As of March 31, 2020
20,227
10,536
52.1
(Reference) Equity: As of
June 30, 2020: ¥10,491
million
As of March 31, 2020: ¥10,536 million
2. Dividends
Annual dividends
1st
2nd
3rd
Year-end
Total
quarter-end
quarter-end
quarter-end
Yen
Yen
Yen
Yen
Yen
Fiscal year ended March 31, 2020
-
0.00
-
2.00
2.00
Fiscal year ending March 31, 2021
-
Fiscal year ending March 31, 2021
0.00
-
2.00
2.00
(Forecast)
(Note) Revision to the forecast for dividends announced most recently: No
1
3. Non-Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2021 (April 1, 2020 to March 31, 2021)
(% indicates changes from the previous corresponding period.)
Net sales
Operating income
Ordinary income
Net income
Net income per
share
Million yen
%
Million yen
%
Million yen
%
Million yen
%
Yen
First half
5,300
(0.4)
70
(43.6)
50
(61.1)
40
(32.5)
1.83
Full year
11,300
5.4
250
(20.0)
220
(45.2)
160
-
7.33
(Note) Revision to the financial results forecast announced most recently: No
* Notes:
Accounting policies adopted specially for the preparation of quarterly non-consolidated financial statements: Yes
Changes in accounting policies, changes in accounting estimates and retrospective restatement
Changes in accounting policies due to the revision of accounting standards: No
Changes in accounting policies other than 1) above: No
Changes in accounting estimates: No
Retrospective restatement: No
Total number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares):
June 30, 2020:
21,974,000 shares
March 31, 2020:
21,974,000 shares
2) Total number of treasury shares at the end of the period:
June 30, 2020:
147,604 shares
March 31, 2020:
147,604 shares
3) Average number of shares during the period:
Three months ended June 30, 2020: 21,826,396 shares
Three months ended June 30, 2019: 21,826,876 shares
These non-consolidated financial results are outside the scope of quarterly review procedures conducted by a certified public accountant or an audit firm.
Explanation of the proper use of financial results forecast and other notes
The earnings forecasts and other forward-looking statements herein are based on information that is available and certain assumptions deemed reasonable as of the date of publication of this document. Actual results may differ significantly from these forecasts due to a wide range of factors. Regarding the assumptions that the financial results forecast is based on, and notes with regard to the usage of the financial results forecast, please refer to Page 3 of the attachment of this document Non-Consolidated Financial Results for the Three Months Ended June 30, 2020 (available in Japanese only).
2
Attachments
Original document
Permalink
Disclaimer
Yuki Gosei Kogyo Co. Ltd. published this content on 31 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 July 2020 04:05:12 UTC
Yuki Gosei Kogyo Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of amino acids, chemicals and pharmaceuticals. The amino acids business is involved in the manufacture and sale of amino acids and vitamin ingredients. The chemical products business in involved in the manufacture and sale of the tire cord adhesive raw materials, agricultural chemical intermediates, silicon compounds and other products. The pharmaceuticals business is involved in the manufacture and sale of the pharmaceutical raw materials and intermediates. The commission of manufacture operation business is involved in the contract for manufacture operations through subsidiaries. The Company is also involved in the manufacture and sale of foods, food additives, feed additives, fragrances, and cosmetics, as well as the sale of the related raw materials and products.